To the Editor Brown et al1 analyzed data for a large prospective birth cohort study in Finland and reported that serotonin reuptake inhibitor (SSRI) exposure during pregnancy is associated with later speech and language disorders. The authors’ interpretation was that SSRI use during pregnancy increases the risk for speech and language disorders in offspring. Their analysis is flawed, and applying it to clinical decision making (eg, discontinuing or otherwise avoiding use of SSRIs when otherwise clinically indicated) could have adverse public health consequences.
Miller BJ, Davis MC, Stone MB. Serotonin Reuptake Inhibitor Use During Pregnancy. JAMA Psychiatry. 2017;74(5):539. doi:10.1001/jamapsychiatry.2016.4073
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: